Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Wavegate's StimuLux Earns Breakthrough Status - Orthopedic Design & Technology

What are you searching for?

Sign in
OEM News

Wavegate’s StimuLux Earns Breakthrough Status

Optical reflectometry system for closed-loop adaptive modulation of spinal cord stimulation.

Author Image

By: Sam Brusco

Associate Editor

Wavegate Corporation has earned Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its StimuLux optical reflectometry system for closed-loop adaptive modulation of spinal cord stimulation.
 
“We are pleased the FDA has granted Breakthrough Device designation for our novel StimuLux technology,” Erich Wolf, MD, Ph.D., CEO told the press. “This underscores the urgent need within our society for more effective treatments of chronic, debilitating pain. We are eager to closely collaborate with the FDA as Wavegate works toward advancing the state of the art.”
 
StimuLux is a component of the company’s Ellipse neuromodulation platform, multiple technologies that aim to address unmet neuromodulation clinical needs.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Add Orthopedic Design & Technology as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters

Topics